FDA corrects contact information for the Expedited Investigational New Drug Pilot Program docket, which solicits public input on shortening timelines from drug identification to first-in-human clinical trials.
The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
FDA withdraws approval of 34 new drug applications across multiple applicants whose manufacturers requested withdrawal due to discontinued marketing.
NMFS closes the Atlantic bluefin tuna angling category trophy fishery in Southern New England for 2026 for fish measuring 73 inches or greater curved fork length.
The U.S. Department of Commerce issues a countervailing duty order on steel concrete reinforcing bar from Algeria following an affirmative final determination.
U.S. Commerce Department maintains antidumping duty orders on seamless carbon and alloy steel pipe from Czech Republic, South Korea, Russia, and Ukraine after finding revocation would likely result in continued or recurring dumping.
U.S. Department of Commerce amends its antidumping duty order on common alloy aluminum sheet from Türkiye following a June 17, 2026 Court of International Trade decision affecting the dumping margin assigned to Assan Aluminyum.
HUD rescinded its One Stop Customer Service Privacy Act system of records as of October 30, 2024, consolidating functions into its Customer Relationship Management system.
The U.S. Department of Commerce is investigating whether corrosion-resistant steel products from China completed in Thailand circumvent existing antidumping and countervailing duty orders.
FDA seeks 60 days of public comment on information collection requirements for Biologics License Applications under the Paperwork Reduction Act; deadline for comments is 60 days from Federal Register publication.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
